Company: PFSA
Filing Date: 2025-02-12
Form Type: S-4/A
Source: 0001213900-25-012354
Chunk: 456

Company: Profusa, Inc.
Filing Date: 2025-02-12
Form: S-4/A
Chunk 456
---
 ) |     |   50 | %  |
| Other income                                                             |     |                   |      5 |      |     |   |     17 |   |     |        |    (12 | ) |     |  (71 | )% |
| Total other expense, net                                                 |     |                   | (3,560 |    ) |     |   | (2,216 | ) |     |        | (1,344 | ) |     |   61 | %  |
| Net loss                                                                 |     | $                 | (6,978 |    ) |     | $ | (7,014 | ) |     | $      |     36 |   |     |   (1 | )% |

Research and Development— Research and development expenses decreased by $0.1 million, or 8%, to $1.4 million during the nine months ended September 30, 2024 from $1.5 million during the nine months ended September 30, 2023. The decrease was driven primarily by the decrease in CRO and personnel costs of $0.2 million as a result of the completion of several clinical studies and a reduction of personnel.

259 General and Administrative— General and administrative expenses decreased by $1.2 million, or 35%, to $2.2 million during the nine months ended September 30, 2024 from $3.4 million during the nine months ended September 30, 2023. The decrease was driven primarily by the decrease in Accounting costs of $0.7 million as a result of the change in accounting consultants, a decrease in legal costs of $0.2 million, and a reduction in personnel and other costs of $0.2 million as a result of reduction of headcount. Loss on Change in the Fair Value of the Tasly Convertible Loans— Loss on change in the fair value of the Tasly Convertible Loan was $0.3 million during the nine months ended September 30, 2024. The loss during the nine months ended September 30, 2024 was driven by the remeasurement of the Tasly Convertible Loans. Interest Expense— Interest expense increased by $1.1 million, or 50%, to $3.3 million during the nine months ended September 30, 2024 from $2.2 million during the nine months ended September 30, 2023. The increase was primarily due to the $3.1 million in